CTS
CTS Corporation
CTS's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over CTS overall, supported by stronger valuation and stronger modeled upside.
CTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
CTS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
CTS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $61.01 | — |
| Cheap | 22x | $54.94 | -10% |
| Current | 24x | $61.01 | — |
| Fair | 25x | $62.16 | +1.9% |
| Expensive | 29x | $73.78 | +21% |
Historical ranges are pointers, not guarantees.
CTS has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
CTS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CTS, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
CTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.85 | +13% |
| Q3 2026 | $2.53 | +29% |
| Q2 2026 | $2.38 | +13% |
| Q1 2026 | $2.34 | +19% |
| Q4 2025 | $2.19 | +16% |
| Q3 2025 | $1.96 | +1% |
| Q2 2025 | $2.11 | +19% |
| Q1 2025 | $1.97 | +16% |
| Q4 2024 | $1.89 | -1.6% |
CTS earned $2.53 per share over the past year, up 29% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over CTS on earnings, with more consistent year-over-year improvement.
CTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $149.6M | +4.6% |
| Q2 2026 | $144.8M | +7% |
| Q1 2026 | $139.2M | +11% |
| Q4 2025 | $137.3M | +7.7% |
| Q3 2025 | $143M | +8% |
| Q2 2025 | $135.3M | +4% |
| Q1 2025 | $125.8M | 0% |
| Q4 2024 | $127.4M | +2.2% |
CTS's revenue has grown year over year for eight quarters in a row: $150M last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.4 points |
| Q2 2026 | 19% | +1.7 points |
| Q1 2026 | 16% | +2.8 points |
| Q4 2025 | 17% | +1.6 points |
| Q3 2025 | 15% | -1.6 points |
| Q2 2025 | 17% | +3.2 points |
| Q1 2025 | 13% | +1.4 points |
| Q4 2024 | 15% | +1.9 points |
CTS's operating margin was 17% last quarter, up 2.4 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over CTS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over CTS on profitability, with a higher operating margin.
CTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.1M | +70% |
| Q2 2026 | $28.9M | +15% |
| Q1 2026 | $12.3M | +11% |
| Q4 2025 | $26M | +31% |
| Q3 2025 | $24.2M | -23% |
| Q2 2025 | $25.1M | +67% |
| Q1 2025 | $11.1M | -23% |
| Q4 2024 | $19.9M | -31% |
CTS's free cash flow has been positive every quarter for seven years: $108M over the past year, up 35% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over CTS on cash flow, with more consistent year-over-year improvement.
CTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +8K shares |
| 1 year | -2.4% | -710K shares |
| 3 years | -8.2% | -2.6M shares |
| 5 years | -11% | -3.5M shares |
| Available history | -13% | -4.2M shares |
CTS has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.3M |
| Q2 2026 | $3.4M |
| Q1 2026 | $8.6M |
| Q4 2025 | $16.6M |
| Q3 2025 | $16.6M |
| Q2 2025 | $16.5M |
| Q1 2025 | $6.5M |
| Q4 2024 | $7.8M |
CTS spent $32M buying back its own shares over the past year, down 33% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
CTS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | -0.0x | Net Cash |
CTS has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
CTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 49.7 | Neutral |
CTS's weekly RSI is 54 (neutral) and its Stochastic is 50 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
CTS PE vs Technology Sector
| Metric | CTS | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 13% below |
| PE % | 43 | 35 | 8 pts above |
CTS is trading at 24x earnings, a 13% discount to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over CTS on valuation relative to its sector.
CTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.3 | 4.6% above |
| 20 week MA | $59.4 | 2.7% above |
| 50 week MA | $55.8 | 9.3% above |
| 100 week MA | $49.4 | 24% above |
| 200 week MA | $47.6 | 28% above |
CTS has the edge over MU on trend strength, trading above more of its moving averages.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
CTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $33.7 | +14% |
| 2021 | $33.7 | $36.3 | +7.8% |
| 2022 | $36.3 | $38.9 | +7.1% |
| 2023 | $38.9 | $43.7 | +12% |
| 2024 | $43.7 | $53.1 | +21% |
| 2025 | $53.1 | $44.5 | -16% |
| 2026 YTD | $44.5 | $61.0 | +37% |
CTS has finished higher in five of the last six years. It's up 37% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over CTS on returns for 2026, with the stronger performance.